Future of IO Checkpoint Combinations

1:45 PM - 2:45 PM, Wednesday, June 10, 2020 ・ Room 6C
The proposed panel would feature a combination of senior academic and industry thought leaders with expertise in novel oncology drug discovery, development and commercialization. The panel will address issues related to future strategies for unlocking the potential of checkpoint inhibitors, including the failure of some first generation targets and what some of the new approaches might be.
Moderator
photo
EVP, Oncology Practice Head
Cello Health BioConsulting (Previously Defined Health)
Speakers
photo
Associate Professor, Department of Immunology
MD Anderson Cancer Center
photo
Head of Immunobiology Lab
Massachusetts General Hospital
photo
Senior Vice President and Therapeutic Area Head Oncology
Glaxo Smith Kline
photo
Senior Vice President
Astellas